Skip to content

Clinical trials

Completed Phase 3 Hypogonadism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypogonadism Phase: Phase 3 Status: Completed Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20042
20052
20063
20073
20084
20101
20124
20133
20145
20152
20162
20171
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Repros Therapeutics Inc.8
Eli Lilly and Company3
Endo USA Inc., a Keenova Therapeutics Company3
Antares Pharma Inc.2
Organon and Co2
Abbott1
Amneal Pharmaceuticals, LLC1
Ardana Bioscience Ltd1
Bayer1
Clarus Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypogonadism37
Obesity4
Erectile Dysfunction2
Eunuchism2
Prostatic Neoplasms2
Endocrine System Diseases1
Frailty1
Gonadal Disorders1
Hip Fractures1
Inflammation1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.